- Opioid
epidemic driving search for safer, all-natural alternatives
- Recent
studies indicate that CBD may be an effective treatment for certain
ailments
- Relaxation
on hemp cultivation could pave the way for distribution of CBD products
The continued scourge of opioid addiction across America is
intensifying efforts to find safer alternatives to the use of narcotics. Drug
overdose deaths are now the leading cause of death for Americans under the
age of 55, knocking heart disease from the top position, according to The
New York Times (http://ibn.fm/eGpVT).
As a result, the population mortality rate, on the decline since 1963, is
rising again. Preliminary data indicates that it rose in 2017, marking
possibly, the “third straight year of decline in American life expectancy
rates,” Bloomberg reports (http://ibn.fm/ScOY5).
Still, powerful opioids like fentanyl continue to be employed in pain
management regimens. Recent studies on the use of safer alternatives to manage
one’s health, particularly cannabidiol (CBD), are gaining attention.
Coupled with relaxed restrictions on hemp cultivation, this
has opened up a vista of opportunity for Marijuana Company of America (OTC: MCOA).
Through wholly owned subsidiary hempSMART™, the company delivers all of the
benefits of hemp-derived cannabidiol products, employing its unique affiliate
marketing and distribution platform. MCOA is intent on building a portfolio of
companies that operate in the legal cannabis and industrial hemp industries.
A number of recent studies, highlighted by a
CannabisNewsWire release, indicate that CBD could be a safe alternative to
perniciously addictive opioids (http://ibn.fm/azELY). Moreover, CBD is one component in
Sativex, which has been approved for use in treating chronic pain in Canada and
Europe. The World Health Organization (WHO), in late 2017, issued a statement,
after studying CBD, that reads in part, “In humans, CBD exhibits no effects
indicative of any abuse or dependence potential… To date, there is no evidence
of recreational use of CBD or any public health related problems associated
with the use of pure CBD.” These developments appear to be removing the stigma
that CBD has acquired by being a derivative of the cannabis plant.
The growing interest in CBD has come at a time when efforts
to ease restrictions on the cultivation of hemp in the U.S. are underway. For
example, a number of states have introduced legislation and regulations
allowing for the cultivation of hemp, from which CBD oil can be extracted.
Earlier this year, the Hemp Farming Act, which proposes, among other things, to
remove hemp from Schedule 1 of the CSA, was introduced in the U.S. Senate. As
part of its hemp promotion initiative, the Senate also declared June 4-10 to be
“Hemp History Week”. This hemp hurrah comes after an exile of 60 years.
Commercial cultivation of hemp in the U.S. effectively ceased after 1958.
Together with joint venture partner Global Hemp Group (CSE:
GHG) (OTC: GBHPF), Marijuana Company of America is already executing its plans
to cultivate hemp on a commercial basis in North America, with current
operations underway in New Brunswick, Canada, and Oregon. After promising
results from the 2017 season, the two companies intend to plant a minimum of
125 acres of hemp in New Brunswick this year, increasing that, over the
following three years, to 1,000 acres.
For more information, visit the company’s website at www.MarijuanaCompanyofAmerica.com
About QualityStocks
QualityStocks is
committed to connecting subscribers with companies that have huge potential to
succeed in the short and long-term future. It is part of our mission statement
to help the investment community discover emerging companies that offer
excellent growth potential. We offer several ways for investors to learn more
about investing in these companies as well as find and evaluate them.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the
QualityStocks website applicable to all content provided by QS, wherever
published or re-republished: http://www.qualitystocks.net/disclaimer.php
No comments:
Post a Comment